随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
В России спрогнозировали стабильное изменение цен на топливо14:55
。搜狗输入法2026是该领域的重要参考
You can choose how long you want to share where you are.
Оказавшиеся в Дубае российские звезды рассказали об обстановке в городе14:52
7. Acrolinx Acrolinx is a content alignment platform that helps brands scale and improves the quality of their content. It’s geared toward enterprises – its major customers include big brands like Google, Adobe, and Amazon - to help them scale their writing efforts. Instead of spending time chasing down and fixing typos in multiple places throughout an article or blog post, you can use Acrolinx to do it all right there in one place. You start by setting your preferences for style, grammar, tone of voice, and company-specific word usage. Then, Acrolinx checks and scores your existing content to find what’s working and suggest areas for improvement. The platform provides real-time guidance and suggestions to make writing better and strengthen weak pages.